Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series
Open Forum Infectious Diseases · 30.10.2025 · 12 (11)
DOI: 10.1093/ofid/ofaf649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 22.10.2025. Verfasst von Shawnalyn W Sunagawa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We present pharmacokinetic data on long-acting cabotegravir/rilpivirine (LA CAB/RPV) from two patients during their second and third trimesters. Monthly LA CAB/RPV dosing maintained concentrations above the proposed efficacy thresholds while bimonthly dosing resulted in subtherapeutic RPV concentrations. This highlights the potential of monthly LA CAB/RPV dosing in pregnancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Science, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Antiviral Pharmacology Laboratory, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Pharmacy Practice and Science, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.
- Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Division of General Internal Medicine, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
ORCID-Profile: Shawnalyn W Sunagawa, Carly Cloud Floyd, Sara H Bares, Jennifer M Davis, Jeremy W Snyder, Joshua P Havens
Zitieren
APA
Sunagawa, S. W., Floyd, C. C., Bares, S. H., Podany, A. T., Scarsi, K. K., Mykris, T., Winchester, L., O'Neill, J., Kubat, M., Tran, C., Davis, J. M., Snyder, J. W., & Havens, J. P. (2025). Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series. Open Forum Infectious Diseases, 12(11). https://doi.org/10.1093/ofid/ofaf649
Vancouver
Sunagawa SW, Floyd CC, Bares SH, Podany AT, Scarsi KK, Mykris T, et al. Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series. Open Forum Infectious Diseases. 2025;12(11). doi:10.1093/ofid/ofaf649
BibTeX
@article{Sunagawa2025,
author = {Sunagawa, Shawnalyn W and Floyd, Carly Cloud and Bares, Sara H and Podany, Anthony T and Scarsi, Kimberly K and Mykris, Timothy and Winchester, Lee and O'Neill, Jennifer and Kubat, Maureen and Tran, Christine and Davis, Jennifer M and Snyder, Jeremy W and Havens, Joshua P},
title = {Long-acting Cabotegravir/Rilpivirine for Treatment of HIV During Pregnancy: A Case Series},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {11},
doi = {10.1093/ofid/ofaf649}
}
EUVIMED